HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract

Clinical and Experimental Obstetrics and Gynecology

Volumn 35, Issue 3, 2008, Pages 175-178

  Krambeck, W M ^a   Cadide R M ^a   Dalmarco, E M ^b   De Cordova, C M M ^b  

^a REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

^b Department of Phamaceutical Sciences ^*  (Brazil)

Author keywords

CIN; Genotypes; HPV; Papanicolaou; PCR,??? cancer

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FEMALE GENITAL SYSTEM; GENOTYPE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 49949096392     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Villa L.L.: "Human papillomaviruses and cervical cancer". Arch. Virol., 1997, 142, 413.
2. Chua K.L., Hjerpe A.: "Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma". Microbios, 1996, 85, 127.
3. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L. et al.: "Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study". Br. Med. J., 2002, 325, 572.
4. Stern P.L., Brown M., Stacey S.N., Kitchener H.C., Hampson I., Abdel-Hady E.S. et al.: "Natural HPV immunity and vaccination strategies". J. Clin. Virol., 2000, 19, 57.
5. Munoz N., Franceschi S., Bosetti C., Moreno V., Herrero R., Smith J.S. et al.: "Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study". Lancet., 2002, 359, 1093.
6. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B. et al.: "Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia". Int. J. Cancer, 1993, 54, 656.
7. Koopman L.A., Szuhai K., van Eendenburg J.D., Bezrookove V., Kenter G.G., Schuuring E. et al.: "Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines". Cancer Res., 1999, 59, 5615.
8. Sasagawa T., Basha W., Yamazaki H., Inoue M.: "High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women". Cancer Epidemiol. Biomarkers Prev., 2001, 10, 45.
9. Deluca G.D., Lucero R.H., Martin de Civetta M.T., Vicente L., de Gorodner O.L., Schelover E. et al.: "Human papillomavirus genotypes in women with cervical cytological abnormalities from an area with high incidence of cervical cancer". Rev. Inst. Med. Trop. Sao Paulo, 2004, 46, 9.
10. Giuliano A.R., Papenfuss M., Schneider A., Nour M., Hatch K.: "Risk factors for high-risk type human papillomavirus infection among Mexican-American women". Cancer Epidemiol Biomarkers Prev., 1999, 8, 615.
11. Goncalves M.A., Massad E., Burattini M.N., Villa L.L.: "Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City". Sao Paulo, Brazil, Virology, 2000, 266, 237.
12. Levi J.E., Kleter B., Quint W.G., Fink M.C., Canto C.L., Matsubara R. et al.: "High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil". J. Clin. Microbiol., 2002, 40, 3341.
13. Watts G.: "Commentary: Liquid automation refreshes Dr. Papanicolaou". Br. Med. J., 2007, 335, 35.
14. De Francesco M.A., Gargiulo F., Schreiber C., Ciravolo G., Salinaro F., Manca N.: "Comparison of the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay for detection of high-risk human papillomavirus in women with abnormal Pap smear". J. Virol. Methods, 2008, 147, 10.
15. Kuebler D.L., Illingworth A., Blenc A.M., Wilbur D.C.: "A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation". Cancer, 2007, 111, 339.
16. Coutlee F., Provencher D., Voyer H.: "Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay". J. Clin. Microbiol., 1995, 33, 2058.
17. Cerqueira D.M., Camara G.N., da Cruz M.R., Silva E.O., Brigido Mde M., Carvalho L.G. et al.: "Variants of human papillomavirus types 53, 58 and 66 identified in Central Brazil". Virus Genes., 2003, 26, 83.
18. Hindryckx P., Garcia A., Claeys P., Gonzalez C., Velasquez R., Bogers J. et al.: "Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix". Sex Transm Infect., 2006, 82, 334.
19. Claeys P., Gonzalez C., Gonzalez M., Van Renterghem L., Temmerman M.: "Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women's health clinics in Nicaragua". Sex. Transm. Infect., 2002, 78, 204.
20. Barr E., Tamms G.: "Quadrivalent human papillomavirus vaccine". Clin. Infect. Dis., 2007, 45, 609.
21. Beerens E., Van Renterghem L., Praet M., Sturtewagen Y., Weyers S., Temmerman M. et al.: "Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes". Cytopathology, 2005, 16, 199.
22. Hwang H.S., Park M., Lee S.Y., Kwon K.H., Pang M.G.: "Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 korean women determined by DNA chip". Cancer Epidemiol. Biomarkers Prev., 2004, 13, 2153.
23. Kulmala S.M., Shabalova I.P., Petrovitchev N., Syrjanen K.J., Gyllensten U.B., Syrjanen S.M.: "Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union". J. Med. Virol., 2007, 79, 771.
24. Senba M., Kumatori A., Fujita S., Jutavijittum P., Yousukh A., Moriuchi T. et al.: "The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand". J. Med. Virol., 2006, 78, 1341.
25. Zuna R.E., Allen R.A., Moore W.E., Mattu R., Dunn S.T.: "Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions". Mod. Pathol., 2004, 17, 1314.